Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
Go back to Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002| ORAGENICS (NYSE: OGEN) | Delayed: 0.59 -0.02 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.61 | 52 Week High | $2.12 | |||
| Open | $0.61 | 52 Week Low | $0.33 | |||
| Day High | $0.61 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $-0.45 | |||
| Volume | 35,583 | |||||

